These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38477320)

  • 21. Incidence of subacute sclerosing panencephalitis following measles and measles vaccination in Japan.
    Okuno Y; Nakao T; Ishida N; Konno T; Mizutani H; Fukuyama Y; Sato T; Isomura S; Ueda S; Kitamura I
    Int J Epidemiol; 1989 Sep; 18(3):684-9. PubMed ID: 2807674
    [TBL] [Abstract][Full Text] [Related]  

  • 22. HIV-associated sub-acute sclerosing panencephalitis - an emerging threat?
    Manesh A; Moorthy M; Bandopadhyay R; Rupali P
    Int J STD AIDS; 2017 Aug; 28(9):937-939. PubMed ID: 28077023
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Epidemiology of subacute sclerosing panencephalitis in Okinawa, Japan, 1970-1996].
    Hirayasu K; Nakada Y; Takaesu E; Kamiya K; Hirayama K
    No To Hattatsu; 1999 Jan; 31(1):27-31. PubMed ID: 10025131
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Subacute sclerosing panencephalitis in Wales.
    Sussman J; Compston DA
    Q J Med; 1994 Jan; 87(1):23-34. PubMed ID: 8140214
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Persistent measles infection of the central nervous system: subacute sclerosing panencephalitis.
    Sever JL
    Rev Infect Dis; 1983; 5(3):467-73. PubMed ID: 6879001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The vaccination against measles: effectiveness and care in use (author's transl)].
    Battistini FD
    Ann Sclavo; 1979 Jun; 21 Suppl 1():394-401. PubMed ID: 42365
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Measles vaccination and risk of SSPE.
    Agarwal RK
    Indian Pediatr; 1999 Mar; 36(3):317. PubMed ID: 10713848
    [No Abstract]   [Full Text] [Related]  

  • 28. Measles virus-specific T helper 1/T helper 2-cytokine production in subacute sclerosing panencephalitis.
    Hara T; Yamashita S; Aiba H; Nihei K; Koide N; Good RA; Takeshita K
    J Neurovirol; 2000 Apr; 6(2):121-6. PubMed ID: 10822325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Subacute sclerosing panencephalitis in papua new guinean children: the cost of continuing inadequate measles vaccine coverage.
    Manning L; Laman M; Edoni H; Mueller I; Karunajeewa HA; Smith D; Hwaiwhanje I; Siba PM; Davis TM
    PLoS Negl Trop Dis; 2011 Jan; 5(1):e932. PubMed ID: 21245918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Subacute sclerosing panencephalitis: clinical phenotype, epidemiology, and preventive interventions.
    Mekki M; Eley B; Hardie D; Wilmshurst JM
    Dev Med Child Neurol; 2019 Oct; 61(10):1139-1144. PubMed ID: 30680706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Subacute sclerosing panencephalitis in Northern Ireland: twenty years' experience.
    Morrow JI; Dowey KE; Swallow MW
    Ulster Med J; 1986 Oct; 55(2):124-30. PubMed ID: 3811010
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Subacute sclerosing panencephalitis in Bulgaria (1978-2002).
    Bojinova V; Dimova P; Belopitova L; Mihailov A; Gatcheva N; Mihneva Z; Todorova M
    Neuroepidemiology; 2004; 23(5):254-7. PubMed ID: 15316253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictors of clinical course of subacute sclerosing panencephalitis: experience at the Children's Hospital, Lahore.
    Malik MA; Saeed M; Qureshi AU; Ahmed N; Akram M
    J Coll Physicians Surg Pak; 2010 Oct; 20(10):671-4. PubMed ID: 20943110
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Complications of measles and antimeasles vaccination].
    Reinert P; Lemerle S; Kohout G; Bernaudin F
    Ann Pediatr (Paris); 1984 Jun; 31(6):477-80. PubMed ID: 6147112
    [No Abstract]   [Full Text] [Related]  

  • 35. Functional properties of measles virus proteins derived from a subacute sclerosing panencephalitis patient who received repeated remdesivir treatments.
    Schmitz KS; Handrejk K; Liepina L; Bauer L; Haas GD; van Puijfelik F; Veldhuis Kroeze EJB; Riekstina M; Strautmanis J; Cao H; Verdijk RM; GeurtsvanKessel CH; van Boheemen S; van Riel D; Lee B; Porotto M; de Swart RL; de Vries RD
    J Virol; 2024 Mar; 98(3):e0187423. PubMed ID: 38329336
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Subacute sclerosing panencephalitis in a tertiary care centre in post measles vaccination era.
    Sonia M; Lalit D; Shobha B; Sheffali G; Amandeep S; Veena K; Madhuri B
    J Commun Dis; 2009 Sep; 41(3):161-7. PubMed ID: 22010482
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Subacute sclerosing panencephalitis: fulminant form].
    Grippo J; Cáceres L; Asís A; Grippo T; Ruprecht B; López M
    Rev Neurol; 2003 Mar 16-31; 36(6):536-9. PubMed ID: 12652417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High risk of subacute sclerosing panencephalitis following measles outbreaks in Georgia.
    Khetsuriani N; Sanadze K; Abuladze M; Tatishvili N
    Clin Microbiol Infect; 2020 Jun; 26(6):737-742. PubMed ID: 31707133
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subacute sclerosing panencephalitis: an update.
    Gutierrez J; Issacson RS; Koppel BS
    Dev Med Child Neurol; 2010 Oct; 52(10):901-7. PubMed ID: 20561004
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Subacute sclerosing panencephalitis: clinical and demographic characteristics.
    Rafique A; Amjad N; Chand P; Zaidi SS; Rana MS; Ahmed K; Ibrahim S
    J Coll Physicians Surg Pak; 2014 Aug; 24(8):557-60. PubMed ID: 25149833
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.